Legend Biotech Reports First Quarter 2025 Results and Recent Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Legend Biotech Reports First Quarter 2025 Results and Recent Highlights

TD Cowen Reiterates Buy Rating on Legend Biotech Corp. (LEGN), PT $62, 'We Like The Profile At These Levels'

May 13, 2025 4:38 PM EDT

TD Cowen analyst Yaron Werber reiterated a Buy rating and $62.00 price target on Legend Biotech Corp. (NASDAQ: LEGN).

The analyst comments "Our Take: Carvykti Continues Solid Ramp, With Growth Likely Weighted Towards H2:25 We Like The Profile At These Levels We like the risk/reward of the stock at these levels given a solid sales ramp for Carvykti on the heels of strong demand, especially in... More